Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy
NCT ID: NCT00623298
Last Updated: 2008-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
26 participants
INTERVENTIONAL
2005-01-31
2006-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide
NCT00553956
Treatment Effects of Narrative Exposure Therapy
NCT00660439
NET for SGBV Survivors in Eastern DR Congo
NCT02989987
Trajectories of Psychopathology in Response to NET
NCT02852616
Effectiveness of Narrative Exposure Therapy Among Refugee Children and Adolescents
NCT02425280
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
NET
Narrative Exposure Therapy
3
6-months baseline
6 months-baseline
2
group IPT
group IPT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrative Exposure Therapy
group IPT
6 months-baseline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Psychotic symptoms or current drug or alcohol
13 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
vivo
UNKNOWN
University of Konstanz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Konstanz, vivo
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fogr SOSS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.